CLADRİBİNE +RİTUKSİMAB PROTOKOLÜ

Kaynaklar:

1- Ravandi, F., S. O'Brien, J. Jorgensen, et al. 2011. "Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia." Blood 118(14):3818-3823.

2- Lauria, F., M. Bocchia, G. Marotta, D. Raspadori, P. L. Zinzani and D. Rondelli. 1999. "Weekly administration of 2-chlorodeoxyadenosine in patients with hairy-cell leukemia is effective and reduces infectious complications